Possible pathophysiological mechanisms for the development of depression in carriers of the ε4 allele of the APOE gene include impaired regulation of lipid metabolism, as well as immune–inflammatory imbalance and increased oxidative stress [37]. The gene discussed is APOE; the disease is depressive symptom measurement.